Authors:
NIEUWINT AWM
OSSENKOPPELE G
HEINS YM
VANDERGROEP P
MADAN K
Citation: Awm. Nieuwint et al., IDENTIFICATION OF 4 COMPLEX VARIANTS OF LEUKEMIA SPECIFIC TRANSLOCATIONS BY FISH, Cytogenetics and cell genetics, 81(2), 1998, pp. 187-187
Authors:
LOWENBERG B
VANPUTTEN WLJ
FERRANT A
OSSENKOPPELE G
VELLENGA E
VERDONCK LF
GRATWOHL A
BOOGAERTS MA
Citation: B. Lowenberg et al., PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION AS AN ALTERNATIVE TOAUTOLOGOUS MARROW TRANSPLANTATION IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA, Stem cells, 15, 1997, pp. 177-180
Authors:
DEKKER AW
VANTVEER MB
SIZOO W
HAAK HL
VANDERLELIE J
OSSENKOPPELE G
HUIJGENS PC
SCHOUTEN HC
SONNEVELD P
WILLEMZE R
VERDONCK LF
VANPUTTEN WLJ
LOWENBERG B
Citation: Aw. Dekker et al., INTENSIVE POSTREMISSION CHEMOTHERAPY WITHOUT MAINTENANCE THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 15(2), 1997, pp. 476-482
Authors:
LOWENBERG B
SUCIU S
ARCHIMBAUD E
OSSENKOPPELE G
VERHOEF GEG
VELLENGA E
WIJERMANS P
BERNEMAN Z
DEKKER AW
STRYCKMANS P
SCHOUTEN H
JEHN U
MUUS P
SONNEVELD P
DARDENNE M
ZITTOUN R
Citation: B. Lowenberg et al., USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DURING AND AFTER REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS AGED 61 YEARS AND OLDER WITH ACUTE MYELOID-LEUKEMIA (AML) - FINAL REPORT OF AML-11, A PHASE-III RANDOMIZED STUDY OF THE LEUKEMIA COOPERATIVE GROUP OFANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC-LCG) AND THE DUTCH BELGIAN HEMATOONCOLOGY COOPERATIVE GROUP (HOVON), Blood, 90(8), 1997, pp. 2952-2961
Authors:
SONNEVELD P
LOWENBERG B
VOSSEBELD P
MALKHANDI J
COVELLI A
DEKKER AW
OSSENKOPPELE G
MILLIGAN D
VERHOEF G
FERRANT A
YIN J
GRATWOHL A
KOVACSOVICS T
BURNETT A
Citation: P. Sonneveld et al., DOSE-FINDING STUDY OF PSC833, A NOVEL MDR REVERSING AGENT, WITH DAUNORUBICIN AND ARA-C IN UNTREATED ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 2517-2517
Authors:
LOWENBERG B
SUCIU S
ZITTOUN R
OSSENKOPPELE G
BOOGAERTS MA
WIJERMANS P
VELLENGA E
BERNEMAN Z
DEFFER AW
SONNEVELD P
STRYCKMANS P
SOLBU G
DARDENNE M
DEWITTE T
ARCHIMBAUD E
Citation: B. Lowenberg et al., GM-CSF DURING AS WELL AS AFTER INDUCTION CHEMOTHERAPY (CT) IN ELDERLYPATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) - THE EORTC-HOVON PHASE-III TRIAL (AML-11), Blood, 86(10), 1995, pp. 1719-1719
Authors:
LOWENBERG B
BOOGAERTS MA
VELLENGA E
OSSENKOPPELE G
DEKKER AW
VANDERLELIE J
SCHOUTEN HC
FOPP M
GRATWOHL A
FEY M
GMUR J
VANPUTTEN W
Citation: B. Lowenberg et al., VARIOUS MODALITIES OF USE OF GM-CSF IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A HOVON-SAKK RANDOMIZED STUDY (HOVON-4A), Blood, 86(10), 1995, pp. 2035-2035
Authors:
BOOGAERTS MA
VANPUTTEN W
FERRANT A
OSSENKOPPELE G
DEKKER AW
VELLENGA E
HAGENBEEK A
WIJEMANS P
FEY MJ
GRATWOHL A
LOWENBERG B
Citation: Ma. Boogaerts et al., SHORT AND HIGH-DOSE OF LENOGRASTIM PERMITS PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION (PBPC) IN PATIENTS WITH AML, Blood, 86(10), 1995, pp. 3910-3910
Authors:
DEKKER AW
VANTVEER MB
HAAK HL
VANDERLELIE J
OSSENKOPPELE G
SCHOUTEN HC
SONNEVELD P
VANPUTTEN WLJ
WILLEMZE R
LOWENBERG B
Citation: Aw. Dekker et al., CONVENTIONAL REMISSION INDUCTION FOLLOWED BY INTENSIVE CONSOLIDATION WITHOUT MAINTENANCE THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS FROM A PHASE-II CLINICAL-TRIAL IN 130 PATIENTS, Blood, 84(10), 1994, pp. 10000144-10000144